MAIA Biotechnology, Inc. (MAIA) research
MAIA Biotechnology, Inc.- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $1.32
- As of
MAIA Biotechnology, Inc. (MAIA): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-10.
As of . Source: SEC EDGAR filings for MAIA. Method and limitations.
Share the MAIA intelligence card
See MAIA live in the terminal
Track MAIA's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live MAIA terminal, freeActive signals for MAIA
- highCONSENSUS_BUY
3 tracked funds increased MAIA this 2026Q2, institutional consensus
- highCONSENSUS_BUY
3 tracked funds increased MAIA this 2026Q2, institutional consensus
- mediumNEW_POSITION
RENAISSANCE TECHNOLOGIES LLC new position in MAIA
- mediumNEW_POSITION
CITADEL ADVISORS LLC new position in MAIA
- mediumNEW_POSITION
TWO SIGMA INVESTMENTS, LP new position in MAIA
FREE, NO ACCOUNT
Every signal on MAIA, as it fires
You are seeing 5 of 20 signals recorded on MAIA since 2026-05-30.
The five above landed across 2 days. The other 15 were recorded on 3 other days. 11 of the 20 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in MAIA (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 552641102 · 2026Q2 | $599K | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 552641102 · 2026Q2 | $73K | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 552641102 · 2026Q2 | $36K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, MAIA
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
MAIA against its peers
MAIA's return on equity of -942.7% ranks in the 8th percentile of 19 Biotechnology sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-04-30.
| Metric | MAIA | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | n/a | 2.8M | n/a | 14 |
| Operating margin | n/a | -206.2% | n/a | 12 |
| Net margin | n/a | -238.2% | n/a | 12 |
| Return on equity | -942.7% | -74.2% | 8 | 19 |
Peers (22): GANX, VRCA, ACET, ALDX, CNTB, FBIO, OSTX, KLRS, ATRA, ICCC, PTHS, RNXT, NRXS, PMVP, ACRV, NTRB, CSBR, RLYB, RANI, ONCY, GUTS, TENX. Left out: TELO (no annual filing), BSEM (no annual filing), RLFTY (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-04-30. Every figure is one full fiscal year read from one annual filing (MAIA: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more MAIA signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to MAIAand get the insider, 13F, options, and confluence read in one view.